Treatment of ulcerative colitis with salicylazosulfapyridine (salazopyrin). 1949

J A BARGEN

UI MeSH Term Description Entries
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012459 Salicylates The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis. Salicylate,Salicylic Acids,Acids, Salicylic
D012460 Sulfasalazine A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) Salicylazosulfapyridine,Asulfidine,Azulfadine,Azulfidine,Azulfidine EN,Colo-Pleon,Pleon,Pyralin EN,Salazopyrin,Salazosulfapyridine,Sulfasalazin medac,Sulfasalazin-Heyl,Sulfasalazine FNA,Sulphasalazine,Ucine,Ulcol,ratio-Sulfasalazine,Colo Pleon,Sulfasalazin Heyl,ratio Sulfasalazine

Related Publications

J A BARGEN
January 1986, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
J A BARGEN
November 1968, International surgery,
J A BARGEN
July 1948, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
J A BARGEN
October 1969, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
J A BARGEN
January 1961, Minerva gastroenterologica,
J A BARGEN
January 1953, Journal of the American Medical Association,
J A BARGEN
June 1981, Zeitschrift fur Gastroenterologie. Verhandlungsband,
Copied contents to your clipboard!